[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,242,891
  • Shares Outstanding, K 48,168
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 576 M
  • EBITDA $ 1,144 M
  • 60-Month Beta 1.40
  • Price/Sales 2.80
  • Price/Cash Flow 10.64
  • Price/Book 3.82

Options Overview Details

View History
  • Implied Volatility 57.29% (+2.20%)
  • Historical Volatility 40.10%
  • IV Percentile 90%
  • IV Rank 63.37%
  • IV High 71.52% on 02/17/26
  • IV Low 32.66% on 09/03/25
  • Expected Move (DTE 4) 11.39 (4.88%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 65
  • Volume Avg (30-Day) 374
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 5,228
  • Open Int (30-Day) 6,462
  • Expected Range 222.02 to 244.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.72
  • Number of Estimates 6
  • High Estimate $2.79
  • Low Estimate $2.69
  • Prior Year $3.12
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
178.92 +30.11%
on 06/22/26
237.86 -2.13%
on 07/10/26
+45.29 (+24.15%)
since 06/12/26
3-Month
146.20 +59.24%
on 05/19/26
237.86 -2.13%
on 07/10/26
+54.46 (+30.54%)
since 04/13/26
52-Week
144.26 +61.38%
on 09/25/25
237.86 -2.13%
on 07/10/26
+73.40 (+46.05%)
since 07/11/25

Most Recent Stories

More News
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Collaboration aligns with Charles River’s strategic commitment to building deeper client relationships and accelerating development with alternative methods

ALA : 24.48 (+0.70%)
CRL : 232.80 (-0.26%)
3 Overrated Stocks We’re Skeptical Of

3 Overrated Stocks We’re Skeptical Of

STT : 180.22 (+0.03%)
ETSY : 81.45 (+0.49%)
CRL : 232.80 (-0.26%)
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

CRL : 232.80 (-0.26%)
3 Reasons to Avoid CRL and 1 Stock to Buy Instead

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

CRL : 232.80 (-0.26%)
How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Despite underperforming its industry peers over the past year, analysts remain highly bullish on Charles River Laboratories' long-term prospects.

XLV : 161.47 (+0.39%)
CRL : 232.80 (-0.26%)
IQV : 207.85 (-0.54%)
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies

CRL : 232.80 (-0.26%)
Stocks Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. June E-mini S&P futures (ESM26...

GOOGL : 356.02 (-0.32%)
AAPL : 317.20 (+0.60%)
ADI : 386.27 (-2.37%)
FDXF : 149.60 (+0.05%)
TSLA : 404.25 (-0.86%)
JBL : 324.00 (-1.90%)
AMD : 545.11 (-2.29%)
CME : 241.85 (+0.66%)
SPY : 752.79 (-0.29%)
META : 664.73 (-0.67%)
MU : 928.36 (-5.20%)
QQQ : 718.54 (-0.96%)
Stocks Supported by Chip Stock Strength and Strong US Retail Sales

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.74%. June E-mini S&P futures (ESM26...

AMAT : 578.00 (-4.07%)
AVGO : 394.60 (-1.34%)
VZ : 42.38 (+0.63%)
REXR : 34.12 (+0.26%)
$IUXX : 29,825.11 (+0.33%)
WNC : 12.90 (unch)
ASML : 1,765.16 (-1.79%)
ZNU26 : 108-295 (-0.10%)
ESU26 : 7,595.25 (-0.33%)
T : 21.25 (+0.57%)
QCOM : 184.67 (-2.37%)
JBL : 324.00 (-1.90%)
1 S&P 500 Stock on Our Buy List and 2 We Brush Off

1 S&P 500 Stock on Our Buy List and 2 We Brush Off

HCA : 406.59 (-0.59%)
CRL : 232.80 (-0.26%)
CBRE : 139.53 (-1.08%)
Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd ...

CRL : 232.80 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 241.89
2nd Resistance Point 239.88
1st Resistance Point 236.64
Last Price 232.80
1st Support Level 231.39
2nd Support Level 229.38
3rd Support Level 226.14

See More

52-Week High 237.86
Last Price 232.80
Fibonacci 61.8% 202.10
Fibonacci 50% 191.06
Fibonacci 38.2% 180.02
52-Week Low 144.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.